Literature DB >> 18979203

Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests.

Jie Hong1, Yi-Fei Zhang, Wei-qiong Gu, Yu-wen Zhang, Yu-xia Su, Zhen-ni Chi, Wei-qing Wang, Xiao-ying Li, Guang Ning.   

Abstract

The purpose of this study was to investigate insulin sensitivity and first-phase insulin secretion in obesity with hyperglycemia in 30 and/or 60 min during oral glucose tolerance (OGTT, glucose > or = 11.1 mmol/l, post-loading hyperglycemia, PLH) in Chinese population. A total of 196 nondiabetic subjects were included in the present study, among them 99 had normal glucose tolerance (NGT, subdivided into 32 lean NGT and 67 obese NGT), 74 had obesity with impaired glucose tolerance (IGT) and 23 had obesity with PLH. A standard 75-g oral glucose tolerance test was performed after fasting and at 30 min, 1, 2 and 3 h. Insulin sensitivity index (S(I)) was assessed by the Bergman's minimal model method with frequently sampled intravenous glucose tolerance test (FSIGTT), insulin secretion was determined by acute insulin response to glucose (AIRg). The disposition index (DI), the product of AIRg and S(I) was used to determine whether AIRg was adequate to compensate for insulin resistance. S(I) was significantly equally lower in three obese subgroups. AIRg was significantly increased in obese NGT as compared with lean NGT controls, and reduced to the same extent in IGT and PLH subjects. There was no significant difference among lean NGT, IGT and PLH subjects. DI value was reduced from obese NGT individuals, IGT and PLH subjects had a similar lower level of DI. In conclusion, our present results demonstrated that the pathophysiological basis of obese subjects with PLH were clearly insulin resistance and defective in first-phase insulin secretion as that in IGT subjects in Chinese population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18979203     DOI: 10.1007/s12020-008-9106-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  17 in total

Review 1.  Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes.

Authors:  S E Kahn
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

Review 2.  Follow-up report on the diagnosis of diabetes mellitus.

Authors:  Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

Review 3.  Prediabetes: prediction and prevention trials.

Authors:  Francesco Vendrame; Peter A Gottlieb
Journal:  Endocrinol Metab Clin North Am       Date:  2004-03       Impact factor: 4.741

4.  Hyperglycaemia after glucose loading is a major predictor of preclinical atherosclerosis in nondiabetic subjects.

Authors:  Yi-Fei Zhang; Jie Hong; Wei-Wei Zhan; Xiao-Ying Li; Wei-Qiong Gu; Yi-Sheng Yang; Min Xu; Guang Ning
Journal:  Clin Endocrinol (Oxf)       Date:  2006-02       Impact factor: 3.478

5.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

6.  Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study.

Authors:  Muhammad A Abdul-Ghani; Christopher P Jenkinson; Dawn K Richardson; Devjit Tripathy; Ralph A DeFronzo
Journal:  Diabetes       Date:  2006-05       Impact factor: 9.461

7.  Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

Authors:  S E Kahn; R L Prigeon; D K McCulloch; E J Boyko; R N Bergman; M W Schwartz; J L Neifing; W K Ward; J C Beard; J P Palmer
Journal:  Diabetes       Date:  1993-11       Impact factor: 9.461

8.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.

Authors:  C Weyer; C Bogardus; D M Mott; R E Pratley
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

9.  Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose.

Authors:  J Hong; M-H Gui; W-Q Gu; Y-F Zhang; M Xu; Z-N Chi; Y Zhang; X-Y Li; W-Q Wang; G Ning
Journal:  Diabet Med       Date:  2008-01       Impact factor: 4.359

10.  Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies.

Authors:  G M Steil; A Volund; S E Kahn; R N Bergman
Journal:  Diabetes       Date:  1993-02       Impact factor: 9.461

View more
  2 in total

1.  High-normal 2 h glucose is associated with defects of insulin secretion and predispose to diabetes in Chinese adults.

Authors:  Ziwei Lin; Jian Zhou; Xiaowen Li; Lige Song; Xuhong Hou; Junling Tang; Chen Wang; Weiping Jia
Journal:  Endocrine       Date:  2014-04-08       Impact factor: 3.633

2.  Patterns of Insulin Secretion During First-Phase Insulin Secretion in Normal Chinese Adults.

Authors:  Tao Yuan; Shuoning Song; Tianyi Zhao; Yanbei Duo; Shihan Wang; Junxiang Gao; Shixuan Liu; Yingyue Dong; Rui Li; Yong Fu; Weigang Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-17       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.